Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double-blind, multicentric trial | Zendy

Sandip Shah | Zendy; Dipti Joshi | Zendy

Open Access

Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double-blind, multicentric trial

Author(s) -

Sandip Shah,

Dipti Joshi

Publication year - 2011

Publication title -

industrial psychiatry journal

Language(s) - English

Resource type - Journals

eISSN - 0976-2795

pISSN - 0972-6748

DOI - 10.4103/0972-6748.98411

Subject(s) - paliperidone , olanzapine , akathisia , positive and negative syndrome scale , clinical global impression , risperidone , tolerability , adverse effect , medicine , randomized controlled trial , schizophrenia (object oriented programming) , extrapyramidal symptoms , psychology , psychiatry , antipsychotic , psychosis , alternative medicine , pathology , placebo

Paliperidone is an active metabolite of risperidone and actss through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research